Skip to main content
. 2024 Sep 1;9(3):201–206. doi: 10.22540/JFSF-09-201

Table 1.

clinical variables of 1018 patients who underwent major surgery for urological cancer.

Variables N (%) or median [IQR]
Total 1018
Age, year 72 [67-77]
Male 920 (90.4)
Body mass index, kg/m2 23.2 [21.3-25.1]
ECOG-PS;
0 863 (84.9)
1 138 (13.6)
2 16 (1.6)
Charlson comorbidity index 0 [0-2]
Stage groups of cancer;
≤I 238 (23.4)
II 534 (52.5)
III 206 (20.2)
IV 40 (3.9)
SARC-F questionnaire;
Strength ≥1 84 (8.3)
Assistance with walking ≥1 148 (14.5)
Rise from a chair ≥1 26 (2.6)
Climb stairs ≥1 105 (10.3)
Falls ≥1 83 (8.2)
Surgical form;
Radical cystectomy 124 (12.2)
Radical prostatectomy 612 (60.1)
Radical nephrectomy 55 (5.4)
Partial nephrectomy 140 (13.8)
Radical nephroureterectomy 87 (8.5)
Surgical approaches;
Open 131 (12.9)
Laparoscopic 75 (7.4)
Robot-assisted 812 (79.7)
Operative time, minutes 169 [140-208]
Estimated blood loss, ml 78 [28-203]
Blood transfusion 36 (3.5)
Postoperative complications, highest;
CDC ≤1 805 (79.0)
CDC 2 169 (16.6)
CDC 3 or more 44 (4.3)
Length of hospital stay, day 8 [7-10]

CDC=Clavien-Dindo classification. ECOG-PS=Eastern Cooperative Oncology Group-performance status. IQR=Interquartile range. SARC-F=Simple questionnaire to rapidly diagnose sarcopenia.